This multi-receptor approach distinguishes it from existing licensed medicines such as semaglutide (Ozempic, Wegovy) or tirzepatide licensed in the UK as Mounjaro for type 2 diabetes and as Zepbound for obesity which act on fewer receptor pathways
Parthasarathy G, Kudva YC, Low PA, et al
This special 3-phase formula includes direct GLP-1 stimulation, enhanced GLP-1 longevity, and improved GLP-1 sensitivity
Compounded semaglutide, is not approved or evaluated for safety, efficacy, or quality by FDA
The functional domains of 5 -reductase-2 have been deduced from in vitro mutagenesis-transfection analysis of natural mutations of 5 -reductase-2 gene in cultured mammalian cells 14 , 17 , 18 , and mutagenesis analysis of 5 -reductase-1 isozyme 19
3b and 6b, and Supplementary Figs